Cited by 22Mental Health and Patient InvolvementPsychiatric care and mental health servicesPatient-Provider Communication in Healthcare

Gaining Autonomy & Medication Management (GAM): new perspectives on well-being, quality of life and psychiatric medication

Open access
del Barrio, Lourdes Rodriguez, Cyr, Céline, Benisty, Lisa, Richard, Pierrette·2013·Ciência & Saúde Coletiva

Abstract

Autonomous Medication Management (GAM) is an innovative approach developed in partnership with medication users. It takes their subjective experience into account and strives to place the individual at the center of pharmacological treatment in psychiatry with a view to improving well-being and quality of life. It creates spaces of open dialogue on the issue of medication amongst users, physicians and their family and friends. This article is derived from a research study and presents the principles, practices and main impacts of GAM on how people relate to their medications and the physicians who prescribe them. The major positive effects were the users' clearer understanding of their experience of taking psychiatric medication and their rights, the reduction or elimination of sudden and unsupervised treatment interruptions and the users' sense of having more control over their treatment. It includes inner experience and life, an improved relationship with professionals and space for negotiation with the physician and, lastly, changes to prescriptions that significantly improved well-being and recovery. The distinguishing features of GAM are described and compared with other approaches, giving a voice to people who take medication.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/s1413-81232013001000012

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Evidence stresses the pivotal impact of therapeutic adherence on the quality of healthcare delivery, including increased demand for help and adherence to scheduled appointments, reduced rates of hospitalizations/rehospitalizations, reduction or elimination of sudden and unsupervised treatment interruptions, and decreased hospitalization costs.

    “Evidence also stresses the pivotal impact of therapeutic adherence on the quality of healthcare delivery, including increased demand for help and adherence to scheduled appointments [49], reduced rates of hospitalizations/rehospitalizations [33,61,63,70], reduction or elimination of sudden and unsupervised treatment interruptions [46], and decreased hospitalization costs [63].”
  • Therapeutic adherence is described as a fluid process that reinforces collaborative approaches between the patient and the clinician and improves the relationship with professionals, affecting satisfaction with treatment.

    “Some articles described therapeutic adherence as a fluid process that reinforces the collaborative approaches between the patient and the clinician [38,56,76] and improves the relationship with professionals [46], affecting satisfaction with treatment [34,45,62,77,78].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Hofer A, Kemmler G, Eder U, Honeder M, Hum- mer M, Fleischhacker W. Attitudes towards antip- sychotics among outpatient clinic attendees with schizophrenia. J Clin Psychiatry 2002; 63(1):49-53
  2. Hall W. Harm Reduction Guide to Coming Off Psy- chiatric Drugs. 2 nd Edition. New York: Icarus Project, Freedom Center; 2012. Artigo apresentado em 29/04/2013 Aprovado em 19/05/2013 Versão final apresentada em 06/06/2013 12. 13. 14. 15. 16. 17. 18. 19. 20.
  3. Liberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Clinical antipsychotic trials of intervention effectiveness investigators: Effective- ness of antipsychotic drugs in patients with schizo- phrenia. N Engl J Med 2005; 353(12):1209-1223.
  4. Weiden PJ, Dixon L, Frances A, Appelbaum P, Haas G, Rapkin B. Neuroleptic Noncompliance in Schizo- phrenia. In: Tamminga CA, Schulz SC, editors. Advances in Neuropsychiatry and Psychopharmacol- ogy. Schizophrenia Research. New York: Raven Press; 1991. p. 285-296. Commission de l'éthique, de la science et de la technologie (CEST). Médicaments psychotropes et usages élargis: un regard éthique. Québec: CEST; 2009.

Cited by

Sorted by citations

Authors
del Barrio, L. R., Cyr, C., Benisty, L., & Richard, P.
Affiliations
  • Université de Montréal, Canada
  • Université de Montréal (CA)
Venue
Ciência & Saúde Coletiva
Published
2013-10
Volume
18
Issue
10
Pages
2879-2887
ISSN
1413-8123 (ISSN-L)
OpenAlex
W2048347275
Cited by
21
References
14
Citations by year
2025: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 3 · 2018: 1 · 2017: 1 · 2015: 1 · 2014: 1
FWCI
1.20
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Ciência & Saúde Coletiva (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
  • Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
  • Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
Keywords
psychiatric medication, medication adherence, patient autonomy, well-being, quality of life, patient-professional relationship, medication interruption, patient participation in treatment
MeSH terms
Mental Disorders, Humans, Psychotropic Drugs, Quality of Life, Self Care, Patient Satisfaction, Personal Autonomy, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review